926.5K XNYS Volume
XNYS 21 Mar, 2025 9:45 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Sudhakar Ramakrishna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 1,049 | 1,049 (0%) | 0% | 0 | Common Shares | |
| Robert W. Musslewhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 1,049 | 1,049 (0%) | 0% | 0 | Common Shares | |
| Michelle D. Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.21 per share. | 15 Feb 2025 | 636 | 18,606 (0%) | 0% | 126.2 | 80,270 | Common Shares |
| Aaron E. Alt | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.21 per share. | 15 Feb 2025 | 1,919 | 34,948 (0%) | 0% | 126.2 | 242,197 | Common Shares |
| Snow M. Ola | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. | 02 Dec 2024 | 355 | 27,161 (0%) | 0% | 122.2 | 43,395 | Common Shares |
| Deborah Weitzman | CEO, PSS Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. | 02 Dec 2024 | 632 | 49,129 (0%) | 0% | 122.2 | 77,256 | Common Shares |
| L. Jessica Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. | 02 Dec 2024 | 676 | 60,286 (0%) | 0% | 122.2 | 82,634 | Common Shares |
| Mary Scherer C. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. | 02 Dec 2024 | 90 | 8,662 (0%) | 0% | 122.2 | 11,002 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.29 per share. | 15 Nov 2024 | 5,186 | 70,785 (0%) | 0% | 121.3 | 629,010 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 123.55 per share. | 14 Nov 2024 | 3,504 | 8,752 (0%) | 0% | 123.5 | 432,919 | Common Shares |
| Gregory B. Kenny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 2,812 | 62,492 (0%) | 0% | 0 | Common Shares | |
| David C. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 14,306 (0%) | 0% | 0 | Common Shares | |
| Sheri H. Edison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 13,781 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 31,197 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 26,557 (0%) | 0% | 0 | Common Shares | |
| Robert W. Azelby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 3,018 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 21,801 (0%) | 0% | 0 | Common Shares | |
| Michelle M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,730 | 7,019 (0%) | 0% | 0 | Common Shares | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Sale of securities on an exchange or to another person at price $ 109.39 per share. | 21 Aug 2024 | 16,573 | 75,971 (0%) | 0% | 109.4 | 1,812,920 | Common Shares |
| Stephen M. Mason | CEO, GMPD Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.19 per share. | 15 Aug 2024 | 8,971 | 87,669 (0%) | 0% | 83.2 | 746,297 | Common Shares |
| Stephen M. Mason | CEO, GMPD Segment | Sale of securities on an exchange or to another person at price $ 109.21 per share. | 15 Aug 2024 | 46,598 | 41,071 (0%) | 0% | 109.2 | 5,088,968 | Common Shares |
| Stephen M. Mason | CEO, GMPD Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 5,990 | 0 | - | - | Employee Stock Option (right to buy) | |
| Stephen M. Mason | CEO, GMPD Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 8,971 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mary C. Scherer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 2,380 | 10,837 (0%) | 0% | 106.4 | 253,137 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 1,668 | 12,505 (0%) | 0% | 0 | Common Shares | |
| Mary C. Scherer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 249 | 12,256 (0%) | 0% | 107.9 | 26,870 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 2,355 | 19,916 (0%) | 0% | 106.4 | 250,478 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 108.85 per share. | 15 Aug 2024 | 4,000 | 19,242 (0%) | 0% | 108.9 | 435,400 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 4,819 | 24,735 (0%) | 0% | 0 | Common Shares | |
| Michelle D. Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 1,493 | 23,242 (0%) | 0% | 107.9 | 161,110 | Common Shares |
| Deborah Weitzman | CEO, PSS Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 9,918 | 38,572 (0%) | 0% | 106.4 | 1,054,878 | Common Shares |
| Deborah Weitzman | CEO, PSS Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 2,341 | 49,761 (0%) | 0% | 107.9 | 252,617 | Common Shares |
| Deborah Weitzman | CEO, PSS Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 13,530 | 52,102 (0%) | 0% | 0 | Common Shares | |
| Stephen M. Mason | CEO, GMPD Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. | 15 Aug 2024 | 5,990 | 78,698 (0%) | 0% | 84.3 | 504,777 | Common Shares |
| Aaron E. Alt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 14,271 | 41,671 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Aug 2024 | 943 | 44,496 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 15 Aug 2024 | 3,294 | 45,439 (0%) | 0% | 108 | 355,752 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 1,489 | 48,733 (0%) | 0% | 107.9 | 160,678 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 8,711 | 50,222 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 12,576 | 41,511 (0%) | 0% | 106.4 | 1,337,583 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,457 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 5,980 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 5,230 | 0 | - | - | Employee Stock Option (right to buy) | |
| Stephen M. Mason | CEO, GMPD Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 1,985 | 72,708 (0%) | 0% | 107.9 | 214,201 | Common Shares |
| Aaron E. Alt | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 2,481 | 39,190 (0%) | 0% | 107.9 | 267,725 | Common Shares |
| Aaron E. Alt | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 108.91 per share. | 15 Aug 2024 | 2,323 | 36,867 (0%) | 0% | 108.9 | 252,998 | Common Shares |
| Jason M. Hollar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 30,275 | 230,494 (0%) | 0% | 106.4 | 3,220,049 | Common Shares |
| Jason M. Hollar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 7,875 | 270,807 (0%) | 0% | 107.9 | 849,791 | Common Shares |
| Jason M. Hollar | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.87 per share. | 15 Aug 2024 | 26,716 | 244,091 (0%) | 0% | 108.9 | 2,908,571 | Common Shares |
| Jason M. Hollar | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 109.02 per share. | 15 Aug 2024 | 46,455 | 197,636 (0%) | 0% | 109.0 | 5,064,524 | Common Shares |
| Jason M. Hollar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 48,188 | 278,682 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. | 15 Aug 2024 | 5,230 | 49,726 (0%) | 0% | 84.3 | 440,732 | Common Shares |
| Stephen M. Mason | CEO, GMPD Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 12,047 | 74,693 (0%) | 0% | 0 | Common Shares | |
| Stephen M. Mason | CEO, GMPD Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 20,667 | 62,646 (0%) | 0% | 106.4 | 2,198,142 | Common Shares |
| Stephen M. Mason | CEO, GMPD Segment | Sale of securities on an exchange or to another person at price $ 109.70 per share. | 15 Aug 2024 | 400 | 40,671 (0%) | 0% | 109.7 | 43,880 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. | 15 Aug 2024 | 5,534 | 112,425 (0%) | 0% | 66.4 | 367,624 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 1,985 | 92,544 (0%) | 0% | 107.9 | 214,201 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,139 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 5,534 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 18,807 | 92,261 (0%) | 0% | 106.4 | 2,000,313 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 11,491 | 103,752 (0%) | 0% | 0 | Common Shares | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.91 per share. | 15 Aug 2024 | 3,139 | 106,891 (0%) | 0% | 83.9 | 263,393 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Sale of securities on an exchange or to another person at price $ 106.48 per share. | 15 Aug 2024 | 17,896 | 94,529 (0%) | 0% | 106.5 | 1,905,566 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 109.00 per share. | 15 Aug 2024 | 34,647 | 27,516 (0%) | 0% | 109 | 3,776,523 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. | 15 Aug 2024 | 6,457 | 62,163 (0%) | 0% | 66.4 | 428,939 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.19 per share. | 15 Aug 2024 | 5,980 | 55,706 (0%) | 0% | 83.2 | 497,476 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 2,785 | 22,271 (0%) | 0% | 0 | Common Shares | |
| Deborah Weitzman | CEO, PSS Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 13,926 | 48,490 (0%) | 0% | 0 | Common Shares | |
| Jason M. Hollar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 45,958 | 260,769 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 29,245 | 54,087 (0%) | 0% | 0 | Common Shares | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 41,780 | 111,068 (0%) | 0% | 0 | Common Shares | |
| Stephen M. Mason | CEO, GMPD Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 45,958 | 83,313 (0%) | 0% | 0 | Common Shares | |
| Mary C. Scherer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 2,785 | 13,217 (0%) | 0% | 0 | Common Shares | |
| Robert W. Azelby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 1,288 | 1,288 (0%) | 0% | 0 | Common Shares | |
| Michelle D. Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.93 per share. | 15 Mar 2024 | 664 | 19,486 (0%) | 0% | 109.9 | 72,994 | Common Shares |
| E. Alt Aaron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.55 per share. | 15 Feb 2024 | 1,919 | 27,400 (0%) | 0% | 103.5 | 198,712 | Common Shares |
| D. Michelle Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.55 per share. | 15 Feb 2024 | 664 | 20,150 (0%) | 0% | 103.5 | 68,757 | Common Shares |
| M. Snow Ola | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.08 per share. | 01 Dec 2023 | 382 | 24,842 (0%) | 0% | 107.1 | 40,905 | Common Shares |
| Scherer Mary C. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.08 per share. | 01 Dec 2023 | 217 | 10,432 (0%) | 0% | 107.1 | 23,236 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.08 per share. | 01 Dec 2023 | 638 | 34,564 (0%) | 0% | 107.1 | 68,317 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Sale of securities on an exchange or to another person at price $ 106.31 per share. | 27 Nov 2023 | 36,642 | 35,202 (0%) | 0% | 106.3 | 3,895,411 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. | 27 Nov 2023 | 15,373 | 71,844 (0%) | 0% | 66.4 | 1,021,228 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.19 per share. | 27 Nov 2023 | 6,279 | 56,471 (0%) | 0% | 83.2 | 522,350 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. | 27 Nov 2023 | 5,990 | 50,192 (0%) | 0% | 84.3 | 504,777 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 15,373 | 0 | - | - | Employee Stock Option (right to buy) | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 6,279 | 0 | - | - | Employee Stock Option (right to buy) | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 5,990 | 0 | - | - | Employee Stock Option (right to buy) | |
| David C. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 12,576 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 3,193 | 59,680 (0%) | 0% | 0 | Common Shares | |
| Sheri H. Edison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 12,051 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 29,467 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 20,071 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 24,827 (0%) | 0% | 0 | Common Shares | |
| Sujatha Chandrasekaran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 4,739 (0%) | 0% | 0 | Common Shares | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.90 per share. | 15 Nov 2023 | 5,185 | 79,680 (0%) | 0% | 102.9 | 533,537 | Common Shares |
| Michelle M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 5,289 (0%) | 0% | 0 | Common Shares | |
| Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 4,739 (0%) | 0% | 0 | Common Shares | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. | 28 Aug 2023 | 6,712 | 50,914 (0%) | 0% | 71.4 | 479,438 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 6,712 | 0 | - | - | Employee Stock Option (right to buy) | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Sale of securities on an exchange or to another person at price $ 89.81 per share. | 28 Aug 2023 | 6,712 | 44,202 (0%) | 0% | 89.8 | 602,805 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 2,496 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 2,797 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mary C. Scherer | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 86.27 per share. | 18 Aug 2023 | 20,695 | 10,649 (0%) | 0% | 86.3 | 1,785,358 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. | 18 Aug 2023 | 3,551 | 31,344 (0%) | 0% | 66.4 | 235,893 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.19 per share. | 18 Aug 2023 | 2,616 | 27,793 (0%) | 0% | 83.2 | 217,625 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. | 18 Aug 2023 | 2,496 | 25,177 (0%) | 0% | 84.3 | 210,338 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. | 18 Aug 2023 | 2,797 | 22,681 (0%) | 0% | 71.4 | 199,790 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 3,551 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mary C. Scherer | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 2,616 | 0 | - | - | Employee Stock Option (right to buy) | |
| Aaron E. Alt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 16,593 | 29,319 (0%) | 0% | 0 | Common Shares | |
| Jason M. Hollar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 53,097 | 214,811 (0%) | 0% | 0 | Common Shares | |
| Jason M. Hollar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 20,771 | 161,714 (0%) | 0% | 93.0 | 1,931,495 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 3,907 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 15,031 | 38,223 (0%) | 0% | 93.0 | 1,397,733 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 9,956 | 48,179 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 87.41 per share. | 15 Aug 2023 | 26,193 | 25,893 (0%) | 0% | 87.4 | 2,289,530 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 87.96 per share. | 15 Aug 2023 | 131 | 25,762 (0%) | 0% | 88.0 | 11,523 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Aug 2023 | 538 | 25,224 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. | 15 Aug 2023 | 3,907 | 52,086 (0%) | 0% | 71.4 | 279,077 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 973 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. | 15 Aug 2023 | 973 | 125,678 (0%) | 0% | 84.3 | 81,995 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. | 15 Aug 2023 | 1,142 | 124,705 (0%) | 0% | 71.4 | 81,573 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 13,274 | 123,563 (0%) | 0% | 0 | Common Shares | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 20,010 | 110,289 (0%) | 0% | 93.0 | 1,860,730 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,142 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Sale of securities on an exchange or to another person at price $ 87.68 per share. | 15 Aug 2023 | 10,668 | 84,865 (0%) | 0% | 87.7 | 935,370 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Sale of securities on an exchange or to another person at price $ 90.84 per share. | 15 Aug 2023 | 30,145 | 95,533 (0%) | 0% | 90.8 | 2,738,372 | Common Shares |
| Stephen M. Mason | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 87.40 per share. | 15 Aug 2023 | 18,528 | 45,332 (0%) | 0% | 87.4 | 1,619,347 | Common Shares |
| Stephen M. Mason | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 25,701 | 61,581 (0%) | 0% | 93.0 | 2,389,936 | Common Shares |
| Stephen M. Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 13,274 | 74,855 (0%) | 0% | 0 | Common Shares | |
| Stephen M. Mason | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 86.40 per share. | 15 Aug 2023 | 10,995 | 63,860 (0%) | 0% | 86.4 | 949,968 | Common Shares |
| Stephen M. Mason | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 88.42 per share. | 15 Aug 2023 | 7,977 | 37,355 (0%) | 0% | 88.4 | 705,326 | Common Shares |
| Mary C. Scherer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 1,659 | 19,884 (0%) | 0% | 0 | Common Shares | |
| Mary C. Scherer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 2,852 | 18,225 (0%) | 0% | 93.0 | 265,207 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 1,239 | 12,416 (0%) | 0% | 93.0 | 115,215 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 86.79 per share. | 15 Aug 2023 | 2,000 | 20,814 (0%) | 0% | 86.8 | 173,580 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 10,398 | 22,814 (0%) | 0% | 0 | Common Shares | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 15,487 | 44,202 (0%) | 0% | 0 | Common Shares | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 10,966 | 28,715 (0%) | 0% | 93.0 | 1,019,728 | Common Shares |
| Jason M. Hollar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 38,282 | 182,485 (0%) | 0% | 0 | Common Shares | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.25 per share. | 07 Aug 2023 | 618 | 130,299 (0%) | 0% | 91.3 | 56,393 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 813 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.49 per share. | 07 Aug 2023 | 813 | 130,917 (0%) | 0% | 51.5 | 41,861 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 28,329 | 130,104 (0%) | 0% | 0 | Common Shares | |
| Stephen M. Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 38,282 | 87,282 (0%) | 0% | 0 | Common Shares | |
| Mary C. Scherer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 2,552 | 21,077 (0%) | 0% | 0 | Common Shares | |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 12,760 | 39,681 (0%) | 0% | 0 | Common Shares | |
| Bruce L. Downey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2023 | 1,200 | 52,729 (0%) | 0% | 0 | Common Shares | |
| Jason M. Hollar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.77 per share. | 15 May 2023 | 3,037 | 144,203 (0%) | 0% | 84.8 | 257,446 | Common Shares |
| Jessica L. Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.72 per share. | 15 Mar 2023 | 1,336 | 101,775 (0%) | 0% | 70.7 | 94,482 | Common Shares |
| Michelle D. Greene | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.72 per share. | 15 Mar 2023 | 669 | 13,655 (0%) | 0% | 70.7 | 47,312 | Common Shares |
| Aaron E. Alt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 12,726 | 12,726 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.17 per share. | 01 Dec 2022 | 596 | 29,961 (0%) | 0% | 80.2 | 47,781 | Common Shares |
| Deborah Weitzman | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.17 per share. | 01 Dec 2022 | 380 | 26,921 (0%) | 0% | 80.2 | 30,465 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.21 per share. | 15 Nov 2022 | 5,185 | 120,827 (0%) | 0% | 75.2 | 389,964 | Common Shares |
| Michelle Brennan | Director | Purchase of securities on an exchange or from another person at price $ 74.72 per share. | 14 Nov 2022 | 200 | 3,324 (0%) | 0% | 74.7 | 14,944 | Common Shares |
| Michelle Brennan | Director | Purchase of securities on an exchange or from another person at price $ 76.30 per share. | 14 Nov 2022 | 200 | 3,124 (0%) | 0% | 76.3 | 15,260 | Common Shares |
| Bruce L. Downey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 53,929 (0%) | 0% | 0 | Common Shares | |
| Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 41,631 (0%) | 0% | 0 | Common Shares | |
| David C. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 10,611 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 3,867 | 56,487 (0%) | 0% | 0 | Common Shares | |
| Sheri H. Edison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 10,086 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 27,502 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 18,106 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 22,862 (0%) | 0% | 0 | Common Shares | |
| Sujatha Chandrasekaran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 2,774 (0%) | 0% | 0 | Common Shares | |
| Michelle Brennan | Director | Purchase of securities on an exchange or from another person at price $ 79.74 per share. | 09 Nov 2022 | 150 | 2,924 (0%) | 0% | 79.7 | 11,961 | Common Shares |
| Michelle Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 2,774 (0%) | 0% | 0 | Common Shares | |
| Steven Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 2,774 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 78.87 per share. | 07 Nov 2022 | 19,590 | 31,187 (0%) | 0% | 78.9 | 1,545,063 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 630 | 30,557 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 80.87 per share. | 07 Nov 2022 | 61,216 | 49,000 (0%) | 0% | 80.9 | 4,950,538 | Common Shares |
| Stephen Mason | CEO, Medical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. | 07 Nov 2022 | 12,176 | 110,216 (0%) | 0% | 66.4 | 808,852 | Common Shares |
| Stephen Mason | CEO, Medical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. | 07 Nov 2022 | 4,688 | 98,040 (0%) | 0% | 71.4 | 334,864 | Common Shares |
| Stephen Mason | CEO, Medical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 12,176 | 0 | - | - | Employee Stock Option (right to buy) | |
| Stephen Mason | CEO, Medical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 4,688 | 0 | - | - | Employee Stock Option (right to buy) | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2022 | 406 | 6,659 | - | - | Phantom Stock | |
| Sujatha Chandrasekaran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 466 | 466 (0%) | 0% | 0 | Common Shares | |
| Michelle Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 466 | 466 (0%) | 0% | 0 | Common Shares | |
| Steven Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 466 | 466 (0%) | 0% | 0 | Common Shares | |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 29,952 | 105,699 (0%) | 0% | 69.3 | 2,076,273 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 17,150 | 135,651 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.81 per share. | 15 Aug 2022 | 96,291 | 674,750 (0%) | 0% | 39.8 | 3,833,345 | Common Shares |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 73,685 | 601,065 (0%) | 0% | 69.3 | 5,107,844 | Common Shares |
| Michael C. Kaufmann | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 96,291 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 94,529 | 578,459 (0%) | 0% | 69.3 | 6,552,750 | Common Shares |
| Jason Hollar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 84,322 | 155,446 (0%) | 0% | 0 | Common Shares | |
| Jason Hollar | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 8,206 | 147,240 (0%) | 0% | 69.3 | 568,840 | Common Shares |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 9,687 | 44,491 (0%) | 0% | 69.3 | 671,503 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 12,803 | 50,777 (0%) | 0% | 69.3 | 887,504 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 10,004 | 63,580 (0%) | 0% | 0 | Common Shares | |
| Brian S. Rice | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 9,850 | 37,850 (0%) | 0% | 69.3 | 682,802 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 339 | 126,012 (0%) | 0% | 69.3 | 23,499 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 442 | 442 | - | - | Employee Stock Option (right to buy) | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 15,721 | 143,782 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 17,873 | 125,909 (0%) | 0% | 69.3 | 1,238,956 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.81 per share. | 15 Aug 2022 | 442 | 126,351 (0%) | 0% | 39.8 | 17,596 | Common Shares |
| Stephen Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 17,150 | 115,931 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 22,579 | 93,352 (0%) | 0% | 69.3 | 1,565,176 | Common Shares |
| Patricia M. English | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.32 per share. | 15 Aug 2022 | 1,313 | 9,000 (0%) | 0% | 69.3 | 91,017 | Common Shares |
| Patricia M. English | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 2,144 | 10,313 (0%) | 0% | 0 | Common Shares | |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 36,536 | 118,501 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 132,857 | 672,988 (0%) | 0% | 0 | Common Shares | |
| Jason Hollar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 18,999 | 71,124 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 13,286 | 54,178 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 16,607 | 53,576 (0%) | 0% | 0 | Common Shares | |
| Brian S. Rice | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 13,286 | 47,700 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 23,250 | 128,061 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 29,893 | 98,781 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 531 | 6,280 | - | - | Phantom Stock | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.86 per share. | 28 Jun 2022 | 9,523 | 540,131 (0%) | 0% | 54.9 | 522,432 | Common Shares |
| Jason Hollar | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.61 per share. | 15 May 2022 | 3,392 | 52,125 (0%) | 0% | 55.6 | 188,629 | Common Shares |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 456 | 5,736 | - | - | Phantom Stock | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 15 Mar 2022 | 1,332 | 104,811 (0%) | 0% | 52.6 | 70,077 | Common Shares |
| Brian S. Rice | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.29 per share. | 15 Feb 2022 | 1,960 | 34,414 (0%) | 0% | 52.3 | 102,488 | Common Shares |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 550 | 5,309 | - | - | Phantom Stock | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.23 per share. | 01 Dec 2021 | 2,798 | 549,654 (0%) | 0% | 46.2 | 129,352 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 49.17 per share. | 18 Nov 2021 | 10,000 | 36,969 (0%) | 0% | 49.2 | 491,700 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.44 per share. | 15 Nov 2021 | 4,391 | 81,965 (0%) | 0% | 51.4 | 225,873 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 34,681 | 106,143 (0%) | 0% | 0 | Common Shares | |
| Bruce L. Downey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 51,621 (0%) | 0% | 0 | Common Shares | |
| Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 39,323 (0%) | 0% | 0 | Common Shares | |
| David C. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 8,303 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 11,138 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 6,215 | 52,620 (0%) | 0% | 0 | Common Shares | |
| John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 11,138 (0%) | 0% | 0 | Common Shares | |
| Sheri H. Edison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 7,778 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 25,194 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 15,798 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 20,554 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 592 | 4,594 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 592 | 7,264 | - | - | Phantom Stock | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,969 | 53,254 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Purchase of securities on an exchange or from another person at price $ 53.12 per share. | 15 Oct 2021 | 112 | 30,285 (0%) | 0% | 53.1 | 5,949 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Purchase of securities on an exchange or from another person at price $ 48.88 per share. | 15 Oct 2021 | 212 | 30,173 (0%) | 0% | 48.9 | 10,363 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.63 per share. | 15 Oct 2021 | 726 | 46,969 (0%) | 0% | 48.6 | 35,305 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 19,991 | 86,356 (0%) | 0% | 51.7 | 1,033,535 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 21,277 | 106,347 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 85,106 | 629,817 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 77,365 | 552,452 (0%) | 0% | 51.7 | 3,999,771 | Common Shares |
| Jason Hollar | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 2,785 | 55,517 (0%) | 0% | 51.7 | 143,985 | Common Shares |
| Jason Hollar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 21,277 | 58,302 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 8,511 | 48,631 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 7,739 | 40,892 (0%) | 0% | 51.7 | 400,106 | Common Shares |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 13,540 | 53,358 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 5,663 | 47,695 (0%) | 0% | 51.7 | 292,777 | Common Shares |
| Brian S. Rice | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 6,362 | 36,374 (0%) | 0% | 51.7 | 328,915 | Common Shares |
| Brian S. Rice | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 8,511 | 42,736 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 13,884 | 71,814 (0%) | 0% | 51.7 | 717,803 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 19,342 | 85,698 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 10,395 | 68,888 (0%) | 0% | 51.7 | 537,422 | Common Shares |
| Stephen Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 21,277 | 79,283 (0%) | 0% | 0 | Common Shares | |
| Patricia M. English | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2021 | 2,901 | 8,986 (0%) | 0% | 0 | Common Shares | |
| Patricia M. English | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 15 Aug 2021 | 817 | 8,169 (0%) | 0% | 51.7 | 42,239 | Common Shares |
| Michael C. Kaufmann | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 76,909 | 0 | - | - | Employee Stock Option (right to buy) | |
| Michael C. Kaufmann | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.60 per share. | 12 Aug 2021 | 76,909 | 613,342 (0%) | 0% | 41.6 | 3,199,414 | Common Shares |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.69 per share. | 12 Aug 2021 | 68,631 | 544,711 (0%) | 0% | 51.7 | 3,547,536 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 23,946 | 85,070 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 98,866 | 536,433 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 9,337 | 40,120 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 2,929 | 39,818 (0%) | 0% | 0 | Common Shares | |
| Brian S. Rice | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 8,291 | 34,225 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 18,190 | 66,356 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 7,209 | 58,006 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 506 | 3,941 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 506 | 6,567 | - | - | Phantom Stock | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.28 per share. | 28 Jun 2021 | 6,962 | 437,567 (0%) | 0% | 57.3 | 398,783 | Common Shares |
| Jason Hollar | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.34 per share. | 15 May 2021 | 2,033 | 37,025 (0%) | 0% | 56.3 | 114,539 | Common Shares |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 472 | 3,381 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 472 | 5,966 | - | - | Phantom Stock | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.35 per share. | 15 Mar 2021 | 911 | 48,166 (0%) | 0% | 57.4 | 52,246 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Sale of securities on an exchange or to another person at price $ 51.53 per share. | 26 Feb 2021 | 3,500 | 12,616 (0%) | 0% | 51.5 | 180,355 | Common Shares |
| Brian S. Rice | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.86 per share. | 15 Feb 2021 | 1,353 | 25,934 (0%) | 0% | 51.9 | 70,167 | Common Shares |
| Patricia M. English | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 51.98 per share. | 11 Feb 2021 | 3,291 | 6,085 (0%) | 0% | 52.0 | 171,066 | Common Shares |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 519 | 2,918 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 560 | 5,506 | - | - | Phantom Stock | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.59 per share. | 01 Dec 2020 | 3,206 | 444,529 (0%) | 0% | 54.6 | 175,016 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.43 per share. | 15 Nov 2020 | 4,362 | 61,124 (0%) | 0% | 57.4 | 250,510 | Common Shares |
| Bruce L. Downey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 47,912 (0%) | 0% | 0 | Common Shares | |
| David C. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 4,594 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 5,595 | 46,405 (0%) | 0% | 0 | Common Shares | |
| Sheri H. Edison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 4,069 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 21,485 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 39,616 (0%) | 0% | 0 | Common Shares | |
| Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 35,614 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 7,429 (0%) | 0% | 0 | Common Shares | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 9,988 (0%) | 0% | 0 | Common Shares | |
| John H. Weiland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 7,429 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 12,089 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 16,845 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.64 per share. | 08 Nov 2020 | 6,485 | 447,735 (0%) | 0% | 52.6 | 341,370 | Common Shares |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 594 | 2,399 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 723 | 4,937 | - | - | Phantom Stock | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.37 per share. | 15 Oct 2020 | 593 | 36,889 (0%) | 0% | 48.4 | 28,683 | Common Shares |
| Sheri H. Edison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 730 | 730 (0%) | 0% | 0 | Common Shares | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 1,074 | 12,289 (0%) | 0% | 53.7 | 57,652 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 20,492 | 68,566 (0%) | 0% | 0 | Common Shares | |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 3,080 | 65,486 (0%) | 0% | 53.7 | 165,334 | Common Shares |
| Michael C. Kaufmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 74,516 | 480,995 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 26,775 | 454,220 (0%) | 0% | 53.7 | 1,437,282 | Common Shares |
| Jason Hollar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 18,629 | 39,058 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 2,289 | 30,783 (0%) | 0% | 53.7 | 122,874 | Common Shares |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 7,452 | 33,072 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 11,177 | 39,393 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 1,911 | 37,482 (0%) | 0% | 53.7 | 102,582 | Common Shares |
| Brian S. Rice | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 7,452 | 28,259 (0%) | 0% | 0 | Common Shares | |
| Brian S. Rice | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 972 | 27,287 (0%) | 0% | 53.7 | 52,177 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 2,793 | 59,430 (0%) | 0% | 53.7 | 149,928 | Common Shares |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 13,785 | 62,223 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2020 | 18,629 | 54,087 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.68 per share. | 15 Aug 2020 | 3,290 | 50,797 (0%) | 0% | 53.7 | 176,607 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 401 | 13,363 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 2,717 | 406,479 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 810 | 25,620 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 238 | 28,216 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 429 | 48,438 (0%) | 0% | 0 | Common Shares | |
| Stephen Mason | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 429 | 35,458 (0%) | 0% | 0 | Common Shares | |
| David C. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2020 | 1,255 | 1,255 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2020 | 564 | 1,812 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2020 | 687 | 4,219 | - | - | Phantom Stock | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.55 per share. | 28 Jun 2020 | 6,649 | 403,762 (0%) | 0% | 50.6 | 336,107 | Common Shares |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2020 | 567 | 1,564 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2020 | 690 | 4,405 | - | - | Phantom Stock | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.62 per share. | 15 Mar 2020 | 916 | 48,009 (0%) | 0% | 47.6 | 43,620 | Common Shares |
| Brian S. Rice | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.62 per share. | 15 Feb 2020 | 1,334 | 20,807 (0%) | 0% | 59.6 | 79,533 | Common Shares |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.81 per share. | 16 Jan 2020 | 971 | 24,810 (0%) | 0% | 53.8 | 52,250 | Common Shares |
| Calvin Darden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2020 | 115 | 6,114 | - | - | Phantom Stock | |
| Dean A. Scarborough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2020 | 529 | 653 | - | - | Phantom Stock | |
| J. Michael Losh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2020 | 648 | 2,670 | - | - | Phantom Stock | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.03 per share. | 02 Dec 2019 | 75 | 12,962 (0%) | 0% | 55.0 | 4,127 | Common Shares |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.03 per share. | 02 Dec 2019 | 2,487 | 410,411 (0%) | 0% | 55.0 | 136,860 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.75 per share. | 15 Nov 2019 | 4,144 | 48,074 (0%) | 0% | 54.8 | 226,884 | Common Shares |
| Bruce L. Downey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 44,573 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 36,277 (0%) | 0% | 0 | Common Shares | |
| Carrie S. Cox | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 32,275 (0%) | 0% | 0 | Common Shares | |
| Dean A. Scarborough | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 4,090 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 5,738 | 40,810 (0%) | 0% | 0 | Common Shares | |
| J. Michael Losh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 6,649 (0%) | 0% | 0 | Common Shares | |
| John H. Weiland | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 4,090 (0%) | 0% | 0 | Common Shares | |
| Colleen F. Arnold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 35,103 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 18,146 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 8,750 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 3,424 | 13,506 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.20 per share. | 08 Nov 2019 | 6,638 | 412,898 (0%) | 0% | 53.2 | 353,142 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2019 | 122 | 6,441 | - | - | Phantom Stock | |
| Dean A. Scarborough | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2019 | 182 | 179 | - | - | Phantom Stock | |
| J. Michael Losh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2019 | 694 | 2,224 | - | - | Phantom Stock | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.78 per share. | 15 Oct 2019 | 491 | 27,978 (0%) | 0% | 46.8 | 22,969 | Common Shares |
| Dean A. Scarborough | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2019 | 666 | 666 (0%) | 0% | 0 | Common Shares | |
| John H. Weiland | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2019 | 666 | 666 (0%) | 0% | 0 | Common Shares | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.41 per share. | 15 Aug 2019 | 1,048 | 13,037 (0%) | 0% | 42.4 | 44,446 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 5,952 | 14,085 (0%) | 0% | 0 | Common Shares | |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 26,190 | 52,218 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.41 per share. | 15 Aug 2019 | 10,660 | 419,536 (0%) | 0% | 42.4 | 452,091 | Common Shares |
| Michael C. Kaufmann | Director, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 95,238 | 430,196 (0%) | 0% | 0 | Common Shares | |
| Jon L. Giacomin | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.41 per share. | 15 Aug 2019 | 6,854 | 61,387 (0%) | 0% | 42.4 | 290,678 | Common Shares |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.41 per share. | 15 Aug 2019 | 1,099 | 25,781 (0%) | 0% | 42.4 | 46,609 | Common Shares |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 9,524 | 26,880 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 11,905 | 30,220 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.41 per share. | 15 Aug 2019 | 1,751 | 28,469 (0%) | 0% | 42.4 | 74,260 | Common Shares |
| Brian S. Rice | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 9,524 | 22,141 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2019 | 16,667 | 51,060 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.41 per share. | 15 Aug 2019 | 2,135 | 48,925 (0%) | 0% | 42.4 | 90,545 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2019 | 1,873 | 8,133 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2019 | 3,329 | 18,315 (0%) | 0% | 0 | Common Shares | |
| Jessica L Mayer | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2019 | 3,362 | 34,393 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2019 | 120 | 6,471 | - | - | Phantom Stock | |
| J. Michael Losh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2019 | 682 | 1,579 | - | - | Phantom Stock | |
| Michael C. Kaufmann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2019 | 63,694 | 334,958 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 122 | 6,348 | - | - | Phantom Stock | |
| J. Michael Losh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 694 | 896 | - | - | Phantom Stock | |
| Jon L. Giacomin | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.50 per share. | 15 Feb 2019 | 4,411 | 68,241 (0%) | 0% | 55.5 | 244,811 | Common Shares |
| Brian S. Rice | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2019 | 12,617 | 12,617 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.63 per share. | 16 Jan 2019 | 983 | 17,356 (0%) | 0% | 47.6 | 46,820 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2019 | 119 | 6,222 | - | - | Phantom Stock | |
| J. Michael Losh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2019 | 201 | 201 | - | - | Phantom Stock | |
| J. Michael Losh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2018 | 3,225 | 3,225 (0%) | 0% | 0 | Common Shares | |
| Craig S. Morford | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.83 per share. | 03 Dec 2018 | 317 | 126,301 (0%) | 0% | 54.8 | 17,381 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.83 per share. | 03 Dec 2018 | 36 | 6,260 (0%) | 0% | 54.8 | 1,974 | Common Shares |
| Michael C. Kaufmann | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.83 per share. | 03 Dec 2018 | 1,636 | 271,264 (0%) | 0% | 54.8 | 89,702 | Common Shares |
| Craig S. Morford | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.31 per share. | 15 Nov 2018 | 274 | 126,618 (0%) | 0% | 57.3 | 15,703 | Common Shares |
| Victor L. Crawford | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2018 | 26,028 | 26,028 (0%) | 0% | 0 | Common Shares | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 55.52 per share. | 12 Nov 2018 | 758 | 6,342 (0%) | 0% | 55.5 | 42,084 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 56.04 per share. | 12 Nov 2018 | 46 | 6,296 (0%) | 0% | 56.0 | 2,578 | Common Shares |
| Bruce L. Downey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 41,149 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 32,853 (0%) | 0% | 0 | Common Shares | |
| Carrie S. Cox | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 28,851 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 5,424 | 35,072 (0%) | 0% | 0 | Common Shares | |
| Colleen F. Arnold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 31,679 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 14,722 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 2,162 | 2,162 (0%) | 0% | 0 | Common Shares | |
| Akhil Johri | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 5,326 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2018 | 3,164 | 10,082 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.65 per share. | 08 Nov 2018 | 7,354 | 272,900 (0%) | 0% | 53.6 | 394,542 | Common Shares |
| Jorge M. Gomez | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.65 per share. | 08 Nov 2018 | 1,632 | 39,582 (0%) | 0% | 53.7 | 87,557 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2018 | 106 | 6,091 | - | - | Phantom Stock | |
| Ola M. Snow | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2018 | 4,852 | 15,562 (0%) | 0% | 0 | Common Shares | |
| Ola M. Snow | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.63 per share. | 15 Oct 2018 | 576 | 14,986 (0%) | 0% | 51.6 | 29,739 | Common Shares |
| Patricia B. Morrison | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.45 per share. | 31 Aug 2018 | 2,719 | 30,725 (0%) | 0% | 52.5 | 142,612 | Common Shares |
| Jon L. Giacomin | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 51.95 per share. | 20 Aug 2018 | 2,890 | 72,652 (0%) | 0% | 52.0 | 150,136 | Common Shares |
| Craig S. Morford | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 17,910 | 127,783 (0%) | 0% | 0 | Common Shares | |
| Craig S. Morford | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 891 | 126,892 (0%) | 0% | 50.2 | 44,701 | Common Shares |
| George S. Barrett | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 15,755 | 502,630 (0%) | 0% | 50.2 | 790,428 | Common Shares |
| Patricia B. Morrison | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 1,534 | 33,444 (0%) | 0% | 50.2 | 76,961 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 291 | 7,100 (0%) | 0% | 50.2 | 14,599 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 2,985 | 7,391 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 71,642 | 283,491 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 3,237 | 280,254 (0%) | 0% | 50.2 | 162,400 | Common Shares |
| Pamela O. Kimmet | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 10,348 | 23,691 (0%) | 0% | 0 | Common Shares | |
| Pamela O. Kimmet | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 1,079 | 22,612 (0%) | 0% | 50.2 | 54,133 | Common Shares |
| Jon L. Giacomin | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 3,387 | 75,542 (0%) | 0% | 50.2 | 169,926 | Common Shares |
| Jon L. Giacomin | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 23,881 | 78,929 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 6,766 | 18,764 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 425 | 18,339 (0%) | 0% | 50.2 | 21,322 | Common Shares |
| Jorge M. Gomez | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.17 per share. | 15 Aug 2018 | 597 | 41,214 (0%) | 0% | 50.2 | 29,951 | Common Shares |
| Jorge M. Gomez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 19,900 | 41,811 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2018 | 14 | 5,985 | - | - | Phantom Stock | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2018 | 98 | 5,973 | - | - | Phantom Stock | |
| Pamela O. Kimmet | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.83 per share. | 30 Jun 2018 | 383 | 13,343 (0%) | 0% | 48.8 | 18,702 | Common Shares |
| Jorge M. Gomez | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.16 per share. | 15 May 2018 | 167 | 21,911 (0%) | 0% | 55.2 | 9,212 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2018 | 82 | 5,859 | - | - | Phantom Stock | |
| Jon L. Giacomin | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 68.65 per share. | 15 Feb 2018 | 5,724 | 57,319 (0%) | 0% | 68.7 | 392,953 | Common Shares |
| Jon L. Giacomin | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2018 | 14,684 | 63,043 (0%) | 0% | 0 | Common Shares | |
| Jon L. Giacomin | CEO, Medical Segment | Sale of securities on an exchange or to another person at price $ 69.12 per share. | 15 Feb 2018 | 2,271 | 55,048 (0%) | 0% | 69.1 | 156,972 | Common Shares |
| Patricia B. Morrison | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 66.30 per share. | 14 Feb 2018 | 28,532 | 36,157 (0%) | 0% | 66.3 | 1,891,672 | Common Shares |
| Patricia B. Morrison | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.34 per share. | 14 Feb 2018 | 1,179 | 34,978 (0%) | 0% | 67.3 | 79,394 | Common Shares |
| Michael C. Kaufmann | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 73.90 per share. | 22 Jan 2018 | 18,586 | 211,849 (0%) | 0% | 73.9 | 1,373,505 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2018 | 69 | 5,760 | - | - | Phantom Stock | |
| David J. Anderson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2018 | 34 | 136 | - | - | Phantom Stock | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.49 per share. | 16 Jan 2018 | 934 | 11,998 (0%) | 0% | 71.5 | 66,772 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.19 per share. | 01 Dec 2017 | 43 | 4,406 (0%) | 0% | 59.2 | 2,545 | Common Shares |
| Michael C. Kaufmann | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.19 per share. | 01 Dec 2017 | 551 | 230,435 (0%) | 0% | 59.2 | 32,614 | Common Shares |
| Craig S. Morford | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.07 per share. | 15 Nov 2017 | 285 | 109,873 (0%) | 0% | 57.1 | 16,265 | Common Shares |
| Bruce L. Downey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 37,985 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 29,689 (0%) | 0% | 0 | Common Shares | |
| Carrie S. Cox | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 25,687 (0%) | 0% | 0 | Common Shares | |
| David P. King | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 21,044 (0%) | 0% | 0 | Common Shares | |
| Gregory B. Kenny | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,951 | 29,648 (0%) | 0% | 0 | Common Shares | |
| Clayton M. Jones | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 14,964 (0%) | 0% | 0 | Common Shares | |
| Colleen F. Arnold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 28,515 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 49,188 | 230,986 (0%) | 0% | 0 | Common Shares | |
| David J. Anderson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 9,946 (0%) | 0% | 0 | Common Shares | |
| Patricia A. Hemingway Hall | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 11,558 (0%) | 0% | 0 | Common Shares | |
| Nancy Killefer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2017 | 2,623 | 6,918 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2017 | 76 | 5,690 | - | - | Phantom Stock | |
| David J. Anderson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2017 | 38 | 101 | - | - | Phantom Stock | |
| Donald M. Casey | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.46 per share. | 15 Sep 2017 | 4,748 | 146,503 (0%) | 0% | 67.5 | 320,300 | Common Shares |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.46 per share. | 15 Sep 2017 | 110 | 4,449 (0%) | 0% | 67.5 | 7,421 | Common Shares |
| Michael C. Kaufmann | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.46 per share. | 15 Sep 2017 | 6,331 | 181,798 (0%) | 0% | 67.5 | 427,089 | Common Shares |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.46 per share. | 15 Sep 2017 | 845 | 48,359 (0%) | 0% | 67.5 | 57,004 | Common Shares |
| Craig S. Morford | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 8,944 | 111,507 (0%) | 0% | 0 | Common Shares | |
| Craig S. Morford | Chief Legal/Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 1,349 | 110,158 (0%) | 0% | 66.8 | 90,059 | Common Shares |
| Craig S. Morford | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 43,844 | 43,844 | - | - | Employee Stock Option (right to buy) | |
| Donald M. Casey | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 14,301 | 157,536 (0%) | 0% | 0 | Common Shares | |
| Donald M. Casey | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 70,102 | 70,102 | - | - | Employee Stock Option (right to buy) | |
| Donald M. Casey | CEO, Medical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 6,285 | 151,251 (0%) | 0% | 66.8 | 419,587 | Common Shares |
| George S. Barrett | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 233,673 | 233,673 | - | - | Employee Stock Option (right to buy) | |
| George S. Barrett | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 47,669 | 561,553 (0%) | 0% | 0 | Common Shares | |
| George S. Barrett | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 43,168 | 518,385 (0%) | 0% | 66.8 | 2,881,896 | Common Shares |
| Patricia B. Morrison | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 6,021 | 68,551 (0%) | 0% | 0 | Common Shares | |
| Patricia B. Morrison | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 3,862 | 64,689 (0%) | 0% | 66.8 | 257,827 | Common Shares |
| Patricia B. Morrison | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 29,517 | 29,517 | - | - | Employee Stock Option (right to buy) | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 1,254 | 5,414 (0%) | 0% | 0 | Common Shares | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 6,149 | 6,149 | - | - | Employee Stock Option (right to buy) | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 855 | 4,559 (0%) | 0% | 66.8 | 57,080 | Common Shares |
| Michael C. Kaufmann | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 9,304 | 188,129 (0%) | 0% | 66.8 | 621,135 | Common Shares |
| Michael C. Kaufmann | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 70,102 | 70,102 | - | - | Employee Stock Option (right to buy) | |
| Michael C. Kaufmann | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 14,301 | 197,433 (0%) | 0% | 0 | Common Shares | |
| Pamela O. Kimmet | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 6,021 | 14,253 (0%) | 0% | 0 | Common Shares | |
| Pamela O. Kimmet | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 29,517 | 29,517 | - | - | Employee Stock Option (right to buy) | |
| Pamela O. Kimmet | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 527 | 13,726 (0%) | 0% | 66.8 | 35,183 | Common Shares |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.76 per share. | 15 Aug 2017 | 8,243 | 49,204 (0%) | 0% | 66.8 | 550,303 | Common Shares |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 70,102 | 70,102 | - | - | Employee Stock Option (right to buy) | |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 14,301 | 57,447 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 4,265 | 12,932 (0%) | 0% | 0 | Common Shares | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2017 | 20,908 | 20,908 | - | - | Employee Stock Option (right to buy) | |
| Craig S. Morford | Chief Legal/Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 7,448 | 102,563 (0%) | 0% | 0 | Common Shares | |
| Donald M. Casey | CEO, Medical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 13,034 | 143,235 (0%) | 0% | 0 | Common Shares | |
| George S. Barrett | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 49,653 | 513,884 (0%) | 0% | 0 | Common Shares | |
| Patricia B. Morrison | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 6,827 | 62,530 (0%) | 0% | 0 | Common Shares | |
| Stuart G. Laws | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 1,552 | 4,160 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 13,034 | 183,132 (0%) | 0% | 0 | Common Shares | |
| Michael C. Kaufmann | CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2017 | 3,500 | 170,098 (0%) | 0% | 0 | Common Shares | |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2017 | 10,976 | 43,146 (0%) | 0% | 0 | Common Shares | |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2017 | 64 | 5,597 | - | - | Phantom Stock | |
| David J. Anderson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2017 | 32 | 62 | - | - | Phantom Stock | |
| Pamela O. Kimmet | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.25 per share. | 30 Jun 2017 | 422 | 8,232 (0%) | 0% | 78.3 | 33,022 | Common Shares |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.60 per share. | 12 May 2017 | 23,270 | 55,440 (0%) | 0% | 41.6 | 968,032 | Common Shares |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Sale of securities on an exchange or to another person at price $ 72.87 per share. | 12 May 2017 | 23,270 | 32,170 (0%) | 0% | 72.9 | 1,695,685 | Common Shares |
| Jon L. Giacomin | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2017 | 23,270 | 0 | - | - | Employee Stock Option (right to buy) | |
| Clayton M. Jones | None | Sale of securities on an exchange or to another person at price $ 71.99 per share. | 08 May 2017 | 502 | 0 (0%) | 0% | 72.0 | 36,139 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2017 | 61 | 5,526 | - | - | Phantom Stock | |
| David J. Anderson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2017 | 30 | 30 | - | - | Phantom Stock | |
| George S. Barrett | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2017 | 217,994 | 0 | - | - | Common Shares | |
| George S. Barrett | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 77.23 per share. | 10 Feb 2017 | 217,994 | 464,231 (0%) | 0% | 77.2 | 16,835,677 | Common Shares |
| George S. Barrett | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.94 per share. | 10 Feb 2017 | 217,994 | 682,225 (0%) | 0% | 30.9 | 6,744,734 | Common Shares |
| Calvin Darden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2017 | 66 | 5,470 | - | - | Phantom Stock | |
| Michele A. M. Holcomb | EVP - Strategy & Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2017 | 8,667 | 8,667 (0%) | 0% | 0 | Common Shares | |
| Bruce L. Downey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2016 | 2,447 | 35,362 | - | - | Common Shares | |
| Gregory B. Kenny | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2016 | 2,753 | 26,697 | - | - | Common Shares |